Integration of CT urography improves diagnostic confidence of 68Ga-PSMA-11 PET/CT in prostate cancer patients.

about

Integration of CT urography improves diagnostic confidence of 68Ga-PSMA-11 PET/CT in prostate cancer patients.

Item

http://www.wikidata.org/entity/Q47109640

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Integration of CT urography im ...... T in prostate cancer patients.

@en

Integration of CT urography im ...... T in prostate cancer patients.

@nl

type

Item

label

Integration of CT urography im ...... T in prostate cancer patients.

@en

Integration of CT urography im ...... T in prostate cancer patients.

@nl

prefLabel

Integration of CT urography im ...... T in prostate cancer patients.

@en

Integration of CT urography im ...... T in prostate cancer patients.

@nl

P1476

Integration of CT urography im ...... T in prostate cancer patients.

@en

P2093

Anne K Berger

http://www.w3.org/2001/XMLSchema#string

Christophe Kremer

http://www.w3.org/2001/XMLSchema#string

Clemens Kratochwil

http://www.w3.org/2001/XMLSchema#string

Frederik L Giesel

http://www.w3.org/2001/XMLSchema#string

Hans-Ulrich Kauczor

http://www.w3.org/2001/XMLSchema#string

Hendrik Rathke

http://www.w3.org/2001/XMLSchema#string

Klaus Kopka

http://www.w3.org/2001/XMLSchema#string

Leon Will

http://www.w3.org/2001/XMLSchema#string

Martin T Freitag

http://www.w3.org/2001/XMLSchema#string

Stefan A Koerber

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics, 2012

The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer.

Initial Evaluation of [(18)F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer

Review of salvage therapy for biochemically recurrent prostate cancer: the role of imaging and rationale for systemic salvage targeted anti-prostate-specific membrane antigen radioimmunotherapy.

Sensitivity, Specificity, and Predictors of Positive 68Ga-Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis.

Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with metastatic prostate cancer.

Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer.

F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients.

Reducing radiation in CT urography for hematuria: Effect of using 100 kilovoltage protocol.

Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study.

P2888

s40644-017-0132-6

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S40644-017-0132-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Walter Mier

P577

2017-12-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1099744734

http://www.w3.org/2001/XMLSchema#string

P698

29262870

http://www.w3.org/2001/XMLSchema#string

P932

5738706

http://www.w3.org/2001/XMLSchema#string